[Histiocytic reticulosis with rapidly fatal development in an African].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D001706:Biopsy; D006801:Humans; D007167:Immunotherapy; D008206:Lymphatic Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000628:therapy; D012882:Skin Tests; D012883:Skin Ulcer / Q000209:etiology; D014374:Tuberculin Test
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D011241:Prednisone
Réticulose histiocytaire d'évolution rapidement fatale chez un Africain